Notably, SYNGAP1, also known as RASA5 (Ras GTPase-activating protein 5), functions as a tumour suppressor that downregulates the catalytic activity of Ras, which, in turn, inhibits the epithelial-mesenchymal transition and metastasis [127]. The gene discussed is SYNGAP1; the disease is neoplasm.